ALISO VIEJO, Calif.--(BUSINESS WIRE)--Two new studies demonstrate the cosmetic and dosimetric advantages of the SAVI® breast brachytherapy applicator for treatment of early-stage breast cancer.
The studies were presented as scientific posters at national medical conferences and were drawn from 12 centers participating in the SAVI Collaborative Research Group. Researchers reached two primary conclusions:
1) SAVI radiation therapy provides for excellent or good cosmetic outcomes in the majority of patients.
